 Connection
Ha-Neui Kim to Middle Aged
This is a "connection" page, showing publications Ha-Neui Kim has written about Middle Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.198 |
|
|
|
-
Yeom DH, Sohn KC, Chu MS, Jo DH, Cho EY, Kim HC. Multiple Pyogenic Liver Abscesses Caused by Microperforation of an Idiopathic Cecal Ulcer. Korean J Gastroenterol. 2016 Jan 25; 67(1):44-8.
Score: 0.046
-
Lee S, Kim IH, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Lee CS, Choi CS, Cho EY, Kim HC. Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients. Intervirology. 2010; 53(3):146-53.
Score: 0.030
-
Choi CS, Cho EY, Park R, Kim SJ, Cho JH, Kim HC. X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma. J Med Virol. 2009 Oct; 81(10):1721-5.
Score: 0.030
-
Cho M, Choi CS, Seo GS, Kim TH, Choi SC, Yun KJ, Kim HC. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma]. Korean J Hepatol. 2007 Jun; 13(2):234-8.
Score: 0.025
-
Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20; 35(36):4003-4011.
Score: 0.013
-
Hirakawa M, Matos TR, Liu H, Koreth J, Kim HT, Paul NE, Murase K, Whangbo J, Alho AC, Nikiforow S, Cutler C, Ho VT, Armand P, Alyea EP, Antin JH, Blazar BR, Lacerda JF, Soiffer RJ, Ritz J. Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. JCI Insight. 2016 11 03; 1(18):e89278.
Score: 0.012
-
Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016 Jul 14; 375(2):143-53.
Score: 0.012
-
Cheong HC, Jeong TG, Cho YB, Yang BJ, Kim TH, Kim HC, Cho EY. Metronidazole-induced encephalopathy in a patient with liver cirrhosis. Korean J Hepatol. 2011 Jun; 17(2):157-60.
Score: 0.008
-
Cho EY, Kim HC, Choi CS, Shin SR, Park C, So HS, Kim HJ, Park R, Cho JH, Moon HB. Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients. Cancer Sci. 2010 Aug; 101(8):1905-12.
Score: 0.008
-
Choi CS, Kim KH, Seo GS, Cho EY, Oh HJ, Choi SC, Kim TH, Kim HC, Roh BS. Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2008 Aug 14; 14(30):4834-7.
Score: 0.007
-
Cho JH, Park DS, Kim TH, Yeom JJ, Kim HC, Moon JH, Yang JS. [Genotypes of hepatitis B virus on Jeju island]. Korean J Hepatol. 2004 Mar; 10(1):42-50.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|